The current institutional shareholding score of Gilead Sciences Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 92.19%, representing a quarter-over-quarter decrease of 0.13%. The largest institutional shareholder is ETHSX, holding a total of 10.92M shares, representing 0.84% of shares outstanding, with 850.23% increase in holdings.